Skip to content
AVECTAS
  • Technology
  • Partners
  • Team
    • Leadership Team
    • Board of Directors
    • Scientific Advisory Board
    • Technical Advisory Board
  • News
    • Press Releases
    • In the News
    • Events
  • We’re Hiring
    • Open Positions
    • Values
  • Contact
Menu
  • Technology
  • Partners
  • Team
    • Leadership Team
    • Board of Directors
    • Scientific Advisory Board
    • Technical Advisory Board
  • News
    • Press Releases
    • In the News
    • Events
  • We’re Hiring
    • Open Positions
    • Values
  • Contact
AVECTAS
  • Technology
  • Partners
  • Team
    • Leadership Team
    • Board of Directors
    • Scientific Advisory Board
    • Technical Advisory Board
  • News
    • Press Releases
    • In the News
    • Events
  • We’re Hiring
    • Open Positions
    • Values
  • Contact
Menu
  • Technology
  • Partners
  • Team
    • Leadership Team
    • Board of Directors
    • Scientific Advisory Board
    • Technical Advisory Board
  • News
    • Press Releases
    • In the News
    • Events
  • We’re Hiring
    • Open Positions
    • Values
  • Contact
AVECTAS
  • Technology
  • Partners
  • Team
    • Leadership Team
    • Board of Directors
    • Scientific Advisory Board
    • Technical Advisory Board
  • News
    • Press Releases
    • In the News
    • Events
  • We’re Hiring
    • Open Positions
    • Values
  • Contact
Menu
  • Technology
  • Partners
  • Team
    • Leadership Team
    • Board of Directors
    • Scientific Advisory Board
    • Technical Advisory Board
  • News
    • Press Releases
    • In the News
    • Events
  • We’re Hiring
    • Open Positions
    • Values
  • Contact

PRESS RELEASES

Avectas logo

AVECTAS Appoints Daniel Castro as Chief Business Officer

January 11, 2021
Johnson&Johnson Innovation Labs

Avectas Opens Canadian Development Site

November 5, 2020
UCDAVIS University of California

Avectas and UC Davis Collaborate on Cell Engineering Technology

June 8, 2020
ONK Therapeutics

Avectas and ONK Therapeutics to develop off-the shelf cancer therapy

May 6, 2020
Vycellix Vital Immunomodulators™

Avectas and Vycellix Announce Collaboration to Advance Next-Generation Solutions for the Optimized Manufacture of Cell & Gene Therapies

March 24, 2020
CCRM

Avectas and CCRM Announce Collaboration to Accelerate Development of Novel Technology for Cell Therapies

March 3, 2020
Karolinska Instituet

Avectas joins the new Competence Center for Next-Generation NK Cell-based Cancer Immunotherapy

January 16, 2020
Avectas Raises $10 Million in Equity Finance

Avectas Raises $10 Million in Equity Finance

April 9, 2019
Avectas named ‘Bio Science Lab of the Year’ at The Irish Laboratory Awards 2019

Avectas named ‘Bio Science Lab of the Year’ at The Irish Laboratory Awards 2019

March 7, 2019
Avectas shortlisted in the ‘US- Ireland Research Innovation Awards’

Avectas shortlisted in the ‘US- Ireland Research Innovation Awards’

March 7, 2019
Maynooth team secures €2.1m EU funding for cancer therapy

Maynooth team secures €2.1m EU funding for cancer therapy

March 20, 2018

Copyright © 2020 Avectas. All rights reserved | Privacy Statement
Avectas is covered by international patents, patents pending, design rights, and software copyright.
SOLUPORE® is a trademark of Avectas